The use of F-18 NaF PET/CT versus conventional bone scanning in the assessment of benign and malignant disorders has many advantages, which are discussed at length in this issue. Imaging of a variety of benign and malignant bone diseases is discussed, including the assessment of disease and the monitoring of patient response to therapy. Imaging in pediatric patients is also discussed.
This issue reviews the uses of positron emission tomography (PET) for imaging the musculoskeletal system. Because PET imaging has been particularly effective with regard to imaging of tumors, this issue includes several issues on detecting primary as well as metastatic bone tumors. PET’s use in imaging soft tissue malignancies and musculoskeletal malignancies are also reviewed. This issue also explores the uses of PET for osteoporosis and inflammatory and infectious diseases. The development and applications for alternative radionuclide tracers is also included.